#United States #Charlotte #Aesthetic Treatments #MedShift #Plasma IQ

MedShift Expands Non-Surgical Aesthetic Solutions with Plasma IQ

In a significant development for the aesthetic industry, MedShift Marketplace has announced that it has secured exclusive distribution rights for Plasma IQ, a groundbreaking handheld plasma energy device that has received FDA Class II clearance. This innovative device is poised to transform the landscape of skin tightening and rejuvenation treatments in the United States.

What is Plasma IQ?

Plasma IQ utilizes controlled plasma energy delivered just above the skin's surface to create precise microinjuries, effectively activating the body’s natural healing process. This leads to an increase in fibroblast activity, stimulating the production of collagen and elastin, which subsequently results in immediate tissue contraction and visibly tighter skin. Clinicians can take advantage of this technology to provide patients with impressive results, addressing concerns such as fine lines, skin laxity, scars, and uneven texture.

According to Jamie Adkins, Director of Business Development at MedShift, "Plasma IQ offers a clinically versatile option for addressing skin laxity and texture concerns with minimal invasiveness." This innovation not only showcases MedShift's commitment to expanding access to advanced technologies but also aligns with the growing demand for effective non-surgical aesthetic treatments.

Why is Plasma Fibroblast Technology Gaining Popularity?

As the preference for non-surgical cosmetic procedures rises, patients increasingly seek treatments that deliver significant results with minimal downtime. Plasma IQ meets this demand effectively. Its non-invasive approach allows for skin rejuvenation by promoting collagen and elastin remodeling, making it suitable for use on delicate skin areas that may be difficult to treat with traditional methods.

With growing interest in aesthetic enhancements, Plasma IQ positions itself as a vital tool for practitioners aiming to integrate new technologies into their workflow without substantial interruptions.

Comparing Plasma IQ with Microneedling

While glycyrrhetinic acid therapy and microneedling both promote collagen remodeling, they employ different methodologies and suit distinct clinical uses.

• - Treatment Approach: Microneedling involves creating controlled micro-channels in the skin using sterile needles, while Plasma IQ delivers energy above the skin without direct contact, minimizing tissue damage.
• - Versatility: Plasma IQ accommodates a broader spectrum of concerns than microneedling, including fine lines, laxity, and scarring, while also treating benign lesions and difficult areas with precision.
• - Cost Efficiency: The Plasma IQ device typically has a lower upfront investment and more affordable consumables compared to many microneedling systems, allowing practices to broaden their service offerings with reduced overhead.

MedShift's Role as Exclusive Distributor

MedShift is dedicated to facilitating streamlined purchasing and reliable product fulfillment for providers of Plasma IQ. The company is committed to offering educational resources that contribute to safe and effective treatments, ensuring that practitioners are well-equipped to deliver consistent outcomes. With treatment costs averaging between $500 and $1,000 per session, many clinics can quickly recoup the initial investment through a steady flow of patient visits. This financial model makes Plasma IQ an attractive option for both established clinics and emerging practices looking for high-impact devices with promising profit potential.

About Plasma IQ and MedShift

Plasma IQ represents the latest advancement in aesthetic treatments, being the first FDA Class II handheld plasma device. It delivers focused plasma energy to induce microinjuries on the skin, promising effective renewal and restoration.

MedShift, based in Charlotte, North Carolina, has been transforming business operations since its founding in 2015. Starting with a focus on the medical industry, the company now provides industry-agnostic solutions through its flagship Velocity Enterprise SaaS Platform. This comprehensive platform integrates sales, commerce, virtual payments, and device management into a scalable system that enhances operational efficiency for over 6,000 customers across North America.

As MedShift leads the way in advanced aesthetic technology, their exclusive distribution of Plasma IQ offers a thrilling new avenue for both practitioners and patients seeking superior skincare solutions.